Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220863) titled 'Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai' on Oct. 21.

Study Type: Observational

Primary Sponsor: Feminai

Condition: Breast Cancer Awareness

Recruitment Status: Recruiting

Date of First Enrollment: October 5, 2025

Target Sample Size: 300

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07220863

Published by HT Digital Content Services with permission from Health Daily Digest....